HomeKROS • NASDAQ
add
Keros Therapeutics Inc
Previous close
$14.52
Day range
$14.26 - $14.62
Year range
$9.12 - $72.37
Market cap
588.11M USD
Avg Volume
450.54K
P/E ratio
46.16
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 18.17M | 49,002.70% |
Operating expense | 14.48M | 45.39% |
Net income | -30.70M | 32.17% |
Net profit margin | -168.96 | 99.86% |
Earnings per share | -0.76 | 39.20% |
EBITDA | -39.45M | 21.32% |
Effective tax rate | 6.75% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 690.22M | 70.06% |
Total assets | 757.16M | 66.40% |
Total liabilities | 50.43M | 47.87% |
Total equity | 706.73M | — |
Shares outstanding | 40.62M | — |
Price to book | 0.83 | — |
Return on assets | -12.91% | — |
Return on capital | -13.52% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -30.70M | 32.17% |
Cash from operations | -29.62M | 25.57% |
Cash from investing | -720.00K | -132.26% |
Cash from financing | 17.00K | -99.52% |
Net change in cash | -30.33M | 17.10% |
Free cash flow | -25.12M | 4.96% |
About
Founded
2015
Headquarters
Website
Employees
148
